Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study.

Patch C, Charlton J, Roderick PJ, Gulliford MC.

Am J Kidney Dis. 2011 Jun;57(6):856-62. doi: 10.1053/j.ajkd.2011.01.023. Epub 2011 Apr 2.

PMID:
21458899
2.

The effects of antihypertensive agents on the survival rate of polycystic kidney disease in Han:SPRD rats.

Kanno Y, Okada H, Moriwaki K, Nagao S, Takahashi H, Suzuki H.

Hypertens Res. 2002 Nov;25(6):939-43.

3.

Progress in blood pressure control in autosomal dominant polycystic kidney disease.

Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Duley IT, Gabow PA, Schrier RW.

Am J Kidney Dis. 2000 Aug;36(2):266-71.

PMID:
10922304
4.

Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.

Klahr S, Breyer JA, Beck GJ, Dennis VW, Hartman JA, Roth D, Steinman TI, Wang SR, Yamamoto ME.

J Am Soc Nephrol. 1995 Jun;5(12):2037-47. Erratum in: J Am Soc Nephrol 1995 Oct;6(4):1318.

5.

Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.

Ecder T, Chapman AB, Brosnahan GM, Edelstein CL, Johnson AM, Schrier RW.

Am J Kidney Dis. 2000 Mar;35(3):427-32.

PMID:
10692268
6.

Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.

Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.

Nephrol Dial Transplant. 2008 Feb;23(2):573-9. Epub 2007 Nov 4.

7.

Renal volume in children with ADPKD: size matters.

Chapman AB, Guay-Woodford LM.

Clin J Am Soc Nephrol. 2009 Apr;4(4):698-9. doi: 10.2215/CJN.01410209. Epub 2009 Apr 1. No abstract available.

8.

Hypertension and autosomal dominant polycystic kidney disease.

Schrier RW.

Am J Kidney Dis. 2011 Jun;57(6):811-3. doi: 10.1053/j.ajkd.2011.02.379. No abstract available.

PMID:
21601126
9.

Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease.

Li L, Szeto CC, Kwan BC, Chow KM, Leung CB, Kam-Tao Li P.

Am J Kidney Dis. 2011 Jun;57(6):903-7. doi: 10.1053/j.ajkd.2011.01.019. Epub 2011 Apr 2.

PMID:
21458901
10.
11.

[Relationship between renal size and blood pressure profile in patients with autosomal dominant polycystic kidney disease without renal failure].

Sans Atxer L, Roca-Cusachs A, Torra R, Calero F, Arias P, Ballarin J, Fernández-Llama P.

Nefrologia. 2010;30(5):567-72. doi: 10.3265/Nefrologia.pre2010.May.10418. Spanish.

12.

Transplantation in autosomal dominant polycystic kidney disease without nephrectomy.

Knispel HH, Klän R, Offermann G, Miller K.

Urol Int. 1996;56(2):75-8.

PMID:
8659014
13.
14.

Hypertension and renal injury in experimental polycystic kidney disease.

Kennefick TM, Al-Nimri MA, Oyama TT, Thompson MM, Kelly FJ, Chapman JG, Anderson S.

Kidney Int. 1999 Dec;56(6):2181-90.

PMID:
10594794
15.

Genesis and significance of hypertension in autosomal dominant polycystic kidney disease.

Zeier M, Ritz E, Geberth S, Gonzalo A.

Nephron. 1994;68(2):155-8. Review. No abstract available.

PMID:
7830851
16.

Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.

Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Grünfeld JP, Jungers P.

J Am Soc Nephrol. 1995 Dec;6(6):1634-42.

17.

Hypertension in individuals at risk for autosomal dominant polycystic kidney disease: to screen or not to screen?

Perrone RD, Miskulin DC.

Am J Kidney Dis. 2005 Sep;46(3):557-9. No abstract available.

PMID:
16129219
18.

Making an earlier diagnosis of ADPKD: implications for the treatment of hypertension.

Perrone R, Miskulin DC.

Nephrol News Issues. 2006 Jun;20(7):32, 35-6. Review. No abstract available.

PMID:
16764142
19.

Autosomal dominant polycystic kidney disease: new treatment options and how to test their efficacy.

Wüthrich RP, Serra AL, Kistler AD.

Kidney Blood Press Res. 2009;32(5):380-7. doi: 10.1159/000254338. Epub 2009 Nov 3. Review.

20.

Effects of topical instillation of minocycline hydrochloride on cyst size and renal function in polycystic kidney disease.

Uemasu J, Fujiwara M, Munemura C, Tokumoto A, Kawasaki H.

Clin Nephrol. 1993 Mar;39(3):140-4.

PMID:
8462201
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk